Get startedLog in
    Picture of Modus Therapeutics Holding AB logo

    MODTX — Modus Therapeutics Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Modus Starts Phase II Study With Sevuparin For Treatment Of Chronic Kidney Disease With Anemia

    Picture of Modus Therapeutics Holding AB logoModus Therapeutics Holding AB
    09/12/2024 08:55
    Dec 9 (Reuters) - Modus Therapeutics Holding AB
 MODTX.ST :
    * INITIATES PHASE II STUDY WITH SEVUPARIN FOR TREATMENT OF
CHRONIC
KIDNEY DISEASE WITH ANEMIA

Source text:  ID:nMFN8zZlPr 
Further company coverage:  MODTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Modus Therapeutics Holding AB

    See all news